Title:
The RNA-binding protein Staufen1 as a novel therapeutic target for skeletal muscle atrophy
Agreement Value:
$150,000.00
Agreement Date:
Mar 29, 2022 - Mar 31, 2024
Description:
Skeletal muscle atrophy is a health concern for human on Earth and for astronauts involved in space flight due to decrease in muscle size and strength which increases fatigability and frailty. The success of long-term space flight is partly limited by the health concerns and risks to the astronauts involved in these missions. The focus of this project is to: i) better understand how muscle atrophy occurs; and ii) eventually design novel therapeutic interventions to counteract the devastating impact of atrophy on Earth and in space.
Organization:
Canadian Space Agency
Expected Results:
The Research component of the program provides financial support to organizations to conduct space related research
and development in priority areas. It will support targeted knowledge development and innovation to sustain and enhance the Canadian capacity to use space to address national needs and priorities in the future
Location:
Ottawa, Ontario, CA K1N 6N5
Reference Number:
003-2021-2022-Q4-00070
Report Type:
Grants and Contributions
Recipient's Legal Name:
Ottawa University
Program:
Class Grant and Contribution Program to Support Research, Awareness and Learning in Space Science and Technology
Program Purpose:
This program supports knowledge development and innovation in the CSA's priority areas while increasing the awareness and participation of Canadians in space-related disciplines and activities.
The Research Component aims to support the development of science and technology; foster the continual development of a critical mass of researchers and highly qualified people in Canada; and support information gathering and space-related studies and research pertaining to Canadian Space Agency priorities.